Omega-3 PUFA, received a positive recommendation in the Australian heart failure guidelines whereas all other nutraceuticals are inadequately studied to allow any conclusion on efficacy.
New research found taking omega-3 fatty acid supplements was associated with better brain function in people with coronary artery disease, which increases risk for dementia.
DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells
Dietary supplementation with DPA omega-3 fatty acids has been reported to enhance the sensitivity of tumor cells towards chemotherapy.
Some studies have shown that omega-3 may be beneficial in treating people with depression and some psychiatric disorders.